COPD beyond proximal bronchial obstruction: phenotyping and related tools at the bedside.


Journal

European respiratory review : an official journal of the European Respiratory Society
ISSN: 1600-0617
Titre abrégé: Eur Respir Rev
Pays: England
ID NLM: 9111391

Informations de publication

Date de publication:
30 Jun 2019
Historique:
received: 09 02 2019
accepted: 04 05 2019
entrez: 10 7 2019
pubmed: 10 7 2019
medline: 9 1 2020
Statut: epublish

Résumé

Chronic obstructive pulmonary disease (COPD) is characterised by nonreversible proximal bronchial obstruction leading to major respiratory disability. However, patient phenotypes better capture the heterogeneously reported complaints and symptoms of COPD. Recent studies provided evidence that classical bronchial obstruction does not properly reflect respiratory disability, and symptoms now form the new paradigm for assessment of disease severity and guidance of therapeutic strategies. The aim of this review was to explore pathways addressing COPD pathogenesis beyond proximal bronchial obstruction and to highlight innovative and promising tools for phenotyping and bedside assessment. Distal small airways imaging allows quantitative characterisation of emphysema and functional air trapping. Micro-computed tomography and parametric response mapping suggest small airways disease precedes emphysema destruction. Small airways can be assessed functionally using nitrogen washout, probing ventilation at conductive or acinar levels, and forced oscillation technique. These tests may better correlate with respiratory symptoms and may well capture bronchodilation effects beyond proximal obstruction.Knowledge of inflammation-based processes has not provided well-identified targets so far, and eosinophils probably play a minor role. Adaptative immunity or specific small airways secretory protein may provide new therapeutic targets. Pulmonary vasculature is involved in emphysema through capillary loss, microvascular lesions or hypoxia-induced remodelling, thereby impacting respiratory disability.

Identifiants

pubmed: 31285287
pii: 28/152/190010
doi: 10.1183/16000617.0010-2019
pmc: PMC9488991
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©ERS 2019.

Déclaration de conflit d'intérêts

Conflict of interest: T. Capron has nothing to disclose. Conflict of interest: A. Bourdin reports personal fees from Novartis, Sanofi, Genentech and Chiesi Farma, and grants and personal fees from GSK, AstraZeneca and Boeringher Ingelheim, outside the submitted work. Conflict of interest: T. Perez reports personal fees from Novartis, Chiesi and Boehringer Ingelheim, and grants from Astra Zeneca, outside the submitted work. Conflict of interest: P. Chanez reports grants and personal fees from ALK, Almirall, Boehringer Ingelheim, GSK, AstraZeneca, Novartis, TEVA and Chiesi, and grants from AMU, outside the submitted work.

Références

Thorax. 2012 May;67(5):399-406
pubmed: 22514236
J Clin Invest. 1977 Feb;59(2):203-16
pubmed: 833271
Pediatr Res. 2005 Jul;58(1):15-21
pubmed: 15774846
Respir Res. 2011 May 22;12:67
pubmed: 21600044
Int J Chron Obstruct Pulmon Dis. 2019 Feb 11;14:381-389
pubmed: 30809092
Respir Res. 2018 Nov 20;19(1):223
pubmed: 30454050
Am J Respir Crit Care Med. 2006 Oct 15;174(8):853-7
pubmed: 16799076
Am J Respir Crit Care Med. 2006 Dec 15;174(12):1327-34
pubmed: 17008639
Chest. 2012 Aug;142(2):312-319
pubmed: 22345381
N Engl J Med. 2011 Sep 29;365(13):1184-92
pubmed: 21991892
Eur Respir J. 2017 Feb 8;49(2):
pubmed: 28179436
Thorax. 2003 Apr;58(4):294-8
pubmed: 12668789
Eur Respir Rev. 2011 Mar;20(119):7-22
pubmed: 21357888
Am Rev Respir Dis. 1959 Jul;80(1, Part 2):67-93
pubmed: 13670406
Eur Respir J. 2017 Apr 26;49(4):
pubmed: 28446552
Am J Respir Crit Care Med. 2017 Mar 1;195(5):630-638
pubmed: 27611890
Am J Respir Crit Care Med. 2013 Dec 15;188(12):1413-9
pubmed: 24245748
Am J Respir Crit Care Med. 2018 Jun 15;197(12):1540-1551
pubmed: 29406779
Lancet. 1992 Jun 27;339(8809):1620
pubmed: 1351598
Eur Respir J. 2015 Jun;45(6):1544-56
pubmed: 25700379
Eur Respir J. 2009 May;33(5):1165-85
pubmed: 19407051
Int J Chron Obstruct Pulmon Dis. 2015 May 27;10:975-84
pubmed: 26064045
Eur Respir J. 2011 Sep;38(3):617-27
pubmed: 21310874
Chest. 1993 May;103(5):1429-32
pubmed: 8486022
Am J Respir Crit Care Med. 2016 Jul 15;194(2):178-84
pubmed: 26808615
Eur Respir J Suppl. 1998 Mar;26:6S-8S
pubmed: 9585871
Respirology. 2015 Feb;20(2):209-18
pubmed: 25257934
Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1102-8
pubmed: 10988137
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65
pubmed: 22878278
Chest. 2015 Jun;147(6):1467-1476
pubmed: 25474370
Am J Med. 1972 Jun;52(6):725-37
pubmed: 5030170
Am J Physiol Lung Cell Mol Physiol. 2016 Oct 1;311(4):L696-L703
pubmed: 27496897
Eur Respir J. 2014 Oct;44(4):1002-10
pubmed: 24833761
Eur J Respir Dis Suppl. 1983;127:41-56
pubmed: 6352300
Am J Respir Crit Care Med. 2010 Dec 1;182(11):1344-51
pubmed: 20709816
Am J Respir Crit Care Med. 2017 May 1;195(9):1189-1197
pubmed: 28278391
J Allergy Clin Immunol. 1995 Jan;95(1 Pt 1):60-8
pubmed: 7822665
N Engl J Med. 1978 Jun 8;298(23):1277-81
pubmed: 651978
J Appl Physiol. 1967 Mar;22(3):395-401
pubmed: 4960137
Am J Respir Crit Care Med. 2011 Jul 1;184(1):57-63
pubmed: 21493737
J Appl Physiol (1985). 1992 Mar;72(3):1016-23
pubmed: 1568955
Respirology. 2016 Aug;21(6):984-94
pubmed: 27028849
Chest. 2016 Nov;150(5):1091-1100
pubmed: 27256720
N Engl J Med. 2012 Sep 6;367(10):913-21
pubmed: 22938715
Chest. 2016 Nov;150(5):1080-1090
pubmed: 27452770
Radiology. 2011 Oct;261(1):274-82
pubmed: 21788524
Eur Respir J. 2015 Nov;46(5):1501-3
pubmed: 26160869
Am J Physiol. 1998 Jun;274(6):L908-13
pubmed: 9609729
Curr Vasc Pharmacol. 2013 Jul;11(4):524-30
pubmed: 22022776
Respir Med. 2012 Aug;106(8):1116-23
pubmed: 22613172
Am J Respir Crit Care Med. 2010 Dec 15;182(12):1492-7
pubmed: 20656939
Cytotherapy. 2009;11(6):676-87
pubmed: 19878054
Chest. 2010 Jul;138(1):32-8
pubmed: 20190002
Eur Respir J. 2015 Dec;46(6):1589-1597
pubmed: 26541521
Int J Chron Obstruct Pulmon Dis. 2017 Sep 30;12:2823-2830
pubmed: 29033563
Respir Res. 2009 Aug 14;10:76
pubmed: 19682386
N Engl J Med. 2011 Oct 27;365(17):1567-75
pubmed: 22029978
N Engl J Med. 1991 May 30;324(22):1539-47
pubmed: 2027358
Am J Respir Crit Care Med. 2007 Sep 1;176(5):454-9
pubmed: 17556723
Respir Care. 2015 Mar;60(3):399-405
pubmed: 25389352
Eur Respir J. 2015 Jun;45(6):1519-20
pubmed: 26028613
Chest. 2017 Feb;151(2):358-365
pubmed: 27818328
J Appl Physiol (1985). 2003 Jul;95(1):441-7; discussion 435
pubmed: 12598485
Am J Respir Crit Care Med. 2015 Sep 15;192(6):706-18
pubmed: 26266827
Respir Med. 2011 Jul;105(7):1069-78
pubmed: 21481577
Thorax. 2008 Dec;63(12):1058-63
pubmed: 18757456
Respir Res. 2014 Aug 06;15:89
pubmed: 25096860
Int J Chron Obstruct Pulmon Dis. 2016 Sep 20;11:2321-2327
pubmed: 27703342
Pulm Pharmacol Ther. 2016 Apr;37:89-94
pubmed: 26996272
Am J Respir Crit Care Med. 1996 Sep;154(3 Pt 1):813-6
pubmed: 8810624
Chest. 2008 Oct;134(4):808-814
pubmed: 18842913
J Clin Invest. 2018 Mar 1;128(3):997-1009
pubmed: 29400693
Proc Am Thorac Soc. 2011 Nov;8(6):522-7
pubmed: 22052931
Acad Radiol. 2010 Jan;17(1):93-9
pubmed: 19796970
Nat Med. 2007 May;13(5):567-9
pubmed: 17450149
Am J Respir Crit Care Med. 2019 Aug 15;200(4):454-461
pubmed: 30758975
Respir Physiol Neurobiol. 2013 Oct 1;189(1):42-6
pubmed: 23816601
Histopathology. 2004 Nov;45(5):477-84
pubmed: 15500651
Int J Clin Exp Med. 2015 Nov 15;8(11):21400-6
pubmed: 26885083
Am J Respir Crit Care Med. 2006 May 15;173(10):1114-21
pubmed: 16484677
Respir Med. 2017 Feb;123:48-55
pubmed: 28137496
Chest. 2013 Jun;143(6):1733-1739
pubmed: 23348843
Respir Physiol Neurobiol. 2005 Aug 25;148(1-2):179-94
pubmed: 15990365
Am J Respir Crit Care Med. 2010 Jun 1;181(11):1223-33
pubmed: 20133926
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1605-11
pubmed: 10228134
N Engl J Med. 2004 Jun 24;350(26):2645-53
pubmed: 15215480
N Engl J Med. 1968 Jun 20;278(25):1355-60
pubmed: 5650164
J Clin Invest. 1968 Jun;47(6):1455-65
pubmed: 5653219
J Am Coll Cardiol. 2014 Nov 11;64(19):2000-9
pubmed: 25440095
Eur Respir J. 1992 Nov;5(10):1231-8
pubmed: 1486970
Eur Respir J. 2013 May;41(5):1058-67
pubmed: 22878876
Arch Pathol Lab Med. 1978 Dec;102(12):609-17
pubmed: 363090
Inhal Toxicol. 2007 Sep;19(11):915-23
pubmed: 17849276
N Engl J Med. 2016 May 12;374(19):1811-21
pubmed: 27168432
Am J Respir Cell Mol Biol. 2018 Mar;58(3):288-298
pubmed: 29087726
N Engl J Med. 2017 Sep 7;377(10):911-922
pubmed: 28877023
Respir Med. 2014 Feb;108(2):344-50
pubmed: 24144670
Eur Respir J. 2014 Apr;43(4):1051-8
pubmed: 24072211
Eur Respir J. 2013 Nov;42(5):1194-204
pubmed: 23429917
Eur Respir J. 2004 Feb;23(2):232-40
pubmed: 14979497
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Am J Respir Crit Care Med. 2015 Apr 15;191(8):873-5
pubmed: 25876202
Eur Respir Rev. 2011 Mar;20(119):23-33
pubmed: 21357889
Expert Opin Ther Targets. 2016 Jul;20(7):869-83
pubmed: 26781659
Thorax. 2016 Sep;71(9):830-7
pubmed: 27084957
Nat Med. 2012 Nov;18(11):1711-5
pubmed: 23042237
Radiology. 2015 Oct;277(1):192-205
pubmed: 25961632
J Clin Invest. 1950 Jun;29(6):805-6
pubmed: 15436705
Clin Sci. 1952 Feb;11(1):21-32
pubmed: 14896515
Am J Physiol Lung Cell Mol Physiol. 2016 Oct 1;311(4):L687-L695
pubmed: 27542809
Br Med J. 1977 Jun 25;1(6077):1645-8
pubmed: 871704
N Engl J Med. 2010 Jan 21;362(3):217-27
pubmed: 20089972
Am J Respir Crit Care Med. 2014 Dec 15;190(12):1355-62
pubmed: 25354273
Chest. 2004 May;125(5):1726-34
pubmed: 15136383
J Clin Invest. 2000 Dec;106(11):1311-9
pubmed: 11104784
Am J Respir Crit Care Med. 2015 Sep 1;192(5):570-80
pubmed: 26067761
Am J Respir Crit Care Med. 2017 Dec 1;196(11):1372-1379
pubmed: 28661698
Am J Respir Crit Care Med. 2005 Apr 1;171(7):734-42
pubmed: 15563631
Lancet Respir Med. 2018 Jul;6(7):526-534
pubmed: 29628377
JAMA Intern Med. 2015 Sep;175(9):1539-49
pubmed: 26098755
J Clin Invest. 2007 Nov;117(11):3551-62
pubmed: 17965775
Am J Respir Crit Care Med. 2018 Oct 15;198(8):1000-1011
pubmed: 29746142
Eur Respir J. 2008 Aug;32(2):472-86
pubmed: 18669788
Respiration. 2015;90(2):97-104
pubmed: 26066063
Chest. 2013 May;143(5):1436-1443
pubmed: 23648907
Respir Res. 2013 May 27;14:59
pubmed: 23711184
Pulm Pharmacol Ther. 2010 Dec;23(6):493-500
pubmed: 20471487
Lab Invest. 1996 Aug;75(2):211-9
pubmed: 8765321
Eur Respir Rev. 2014 Sep;23(133):350-5
pubmed: 25176971
Am J Respir Crit Care Med. 2004 Oct 15;170(8):857-62
pubmed: 15151920
Eur Respir J. 1997 Jun;10(6):1285-91
pubmed: 9192930
N Engl J Med. 2009 Jun 4;360(23):2445-54
pubmed: 19494220
Am J Respir Crit Care Med. 2016 May 1;193(9):965-74
pubmed: 26641631
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582
pubmed: 28128970
Int J Chron Obstruct Pulmon Dis. 2015 Nov 23;10:2549-57
pubmed: 26648712
Lancet Respir Med. 2015 Aug;3(8):613-20
pubmed: 26159408
Am J Respir Crit Care Med. 2010 Feb 1;181(3):218-25
pubmed: 19875683
Am J Med. 2014 Jan;127(1):94.e7-23
pubmed: 24384106
Pharmacol Rev. 2004 Dec;56(4):515-48
pubmed: 15602009
Int J Chron Obstruct Pulmon Dis. 2017 Dec 22;13:79-89
pubmed: 29317813
Am J Respir Crit Care Med. 2018 May 1;197(9):1216-1219
pubmed: 29035097
Chest. 2003 Oct;124(4):1373-80
pubmed: 14555568
Pulm Circ. 2011 Jul-Sep;1(3):320-6
pubmed: 22140621
Am Rev Respir Dis. 1991 May;143(5 Pt 1):922-7
pubmed: 2024844
Am J Respir Crit Care Med. 2019 Mar 15;199(6):715-727
pubmed: 30352166
Eur Respir J. 2005 Sep;26(3):523-48
pubmed: 16135737
Respir Physiol. 1987 Oct;70(1):113-20
pubmed: 3659606
Multidiscip Respir Med. 2017 Sep 27;12:25
pubmed: 28959443
Respir Res. 2010 Sep 10;11:122
pubmed: 20831787
J Appl Physiol (1985). 1997 Dec;83(6):1907-16
pubmed: 9390962
Clin Physiol Funct Imaging. 2016 May;36(3):211-7
pubmed: 25393655
Chest. 2013 Jul;144(1):136-144
pubmed: 23450302

Auteurs

Thibaut Capron (T)

Clinique des Bronches, Allergies et Sommeil, Hôpital Nord, Assistance Publique des Hôpitaux de Marseille, Aix Marseille Université, Marseille, France.

Arnaud Bourdin (A)

Université de Montpellier, PhyMedExp, INSERM, CNRS, CHU de Montpellier, Dept of Respiratory Diseases, Montpellier, France.

Thierry Perez (T)

Dept of Respiratory Diseases, CHU Lille, Center for Infection and Immunity of Lille, INSERM U1019 - CNRS UMR 8204, Université Lille Nord de France, Lille, France.

Pascal Chanez (P)

Clinique des Bronches, Allergies et Sommeil, Hôpital Nord, Assistance Publique des Hôpitaux de Marseille, Aix Marseille Université, Marseille, France pascal.chanez@univ-amu.fr.
Aix Marseille Université, INSERM, INRA, CV2N, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH